Picture of Stryker logo

SYK Stryker Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Stryker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KPRESS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue17,10818,44920,49822,59525,116
Cost of Revenue
Gross Profit11,00111,63713,09914,51916,218
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses14,52015,60816,61018,90620,227
Operating Profit2,5882,8413,8883,6894,889
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes2,2812,6833,6733,4924,514
Provision for Income Taxes
Net Income After Taxes1,9942,3583,1652,9933,246
Net Income Before Extraordinary Items
Net Income1,9942,3583,1652,9933,246
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,9942,3583,1652,9933,246
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS7.948.719.3911.28.78
Dividends per Share